Bayer Zydus Pharma Products

Specialty Medicine

The Specialty Medicine Business Unit offers innovative therapeutic options to improve the lives of people suffering from severe, chronic and life-threatening diseases. Products from the Specialty Medicine division of Bayer Zydus Pharma include:

It is Indicated for
1. Clinically Isolated Syndrome (CIS)- A single clinical event suggestive of Multiple Sclerosis (MS).
2. Relapsing-remitting and secondary progressive multiple sclerosis.
It is indicated for the treatment of Neovascular (wet) age-related macular degeneration (wet AMD)
"It is indicated for the treatment of patients with metastatic colorectal cancer (CRC) who have been previously treated with, fluoropyrimidine, oxaliplatin and irinotecan based chemotherapy, an anti-VEGF therapy, and, if KRAS wild type, an anti-EGFR therapy"
It is an Anti- VEGF targeted systemic therapy. Currently indicated for advanced kidney cancer & liver cancer preventing the further tumor growth and prolonging the life of the patient.